Robert S. Svatek

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

Dipen J. Parekh, Isildinha M. Reis, Erik P. Castle et al. · The Lancet · 2018 · 763 citations

Medicine, Surgery, Urology +16

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text

Medicine, Oncology, Urology +13

Perioperative Outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy

Dipen J. Parekh, Jamie Messer, John FitzGerald et al. · The Journal of Urology · 2012 · 283 citations

Medicine, Surgery, Urology +17

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence

Edward M. Messing, Catherine M. Tangen, Seth P. Lerner et al. · JAMA · 2018 · 237 citations · Full text

Medicine, Oncology, Urology +17

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

Évanguelos Xylinas, Matthew Kent, Luis A. Kluth et al. · British Journal of Cancer · 2013 · 229 citations · Full text

Medicine, Oncology, Urology +10